SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-17-008676
Filing Date
2017-01-12
Accepted
2017-01-12 15:31:33
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3/A d300992ds3a.htm S-3/A 187039
2 EX-23.1 d300992dex231.htm EX-23.1 5727
3 GRAPHIC g300992g17a58.jpg GRAPHIC 2229
4 GRAPHIC g300992g43t88.jpg GRAPHIC 2713
5 GRAPHIC g300992g59k25.jpg GRAPHIC 67159
  Complete submission text file 0001193125-17-008676.txt   293672
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-215290 | Film No.: 17525062
SIC: 2834 Pharmaceutical Preparations